The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma

Journal of Clinical Oncology

Volumn 9, Issue 6, 1991, Pages 1045-1049

  Shuster, Jonathan J ^d   Cantor, Alan B ^e   McWilliams, Nancy ^a   Pole, John Graham ^e   Castleberry, Robert P ^e   Marcus, Robert ^e   Pick, Terry ^e   Ide Smith, E ^b   Hayes, F Ann ^c  

^a EASTERN MAINE MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Triton Biosciences Inc ^*  (United States)

^d Pediatric Oncology Group   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMAN; INFANT; MALE; NEUROBLASTOMA; PILOT PROJECTS; PODOPHYLLOTOXIN; PROGNOSIS; REMISSION INDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS;

EID: 0025755376     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.6.1045     Document Type: Article

References (11)

1. Hayes FA, Green AA: Neuroblastoma. Pediatr Ann 12:366-374, 1983
2. Shafford EA, Rogers DW, Pritchard J: Advanced neuroblastoma: Improved response rate using a multi-agent regimen including cisplatin and VM26. J Clin Oncol 2:742-747, 1984
3. Fernbach DJ, Williams TE, Donaldson MH: Neuroblastoma, in Sutow W, Fernbach DJ, Vietti TJ (eds): Clinical Pediatric Oncology (ed 2). St Louis, MO, Mosby, 1484, pp 506-537
4. D'Angio GJ, August C, Elkins W, et al: Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution, in Evans A, D'Angio GJ, Seeger RC (eds): Advances in Neuroblastoma Research. New York, NY, Liss, 1985, pp 557-563
5. August CS, Serota FT, Koch PA, et al: Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol 2:609-616, 1984
6. Pritchard J, McElwain TJ, Graham-Pole J: High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 45:86-94, 1982
7. Pritchard J, Germond D, Jones D, et al: Is high dose melphalan of value in treating advanced neuroblastoma? Preliminary results of a randomized trial by the European Neuroblastoma Study Group. Proc Am Soc Clin Oncol 5:205, 1986 (abstr)
8. Graham Pole J, Casper J, Elfenbein G, et al: High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma. J Clin Oncol 9:152-158, 1991
9. Mantel N, Byar D: Evaluation of response-time data involving transient states: An illustration using heart-transplant data. J Am Stat Assoc 69:81-86, 1974
10. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
11. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977